These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37684690)

  • 1. Retro-miRs: novel and functional miRNAs originating from mRNA retrotransposition.
    Mercuri RLV; Conceição HB; Guardia GDA; Goldstein G; Vibranovski MD; Hinske LC; Galante PAF
    Mob DNA; 2023 Sep; 14(1):12. PubMed ID: 37684690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-128 Restriction of LINE-1 (L1) Retrotransposition Is Dependent on Targeting hnRNPA1 mRNA.
    Fung L; Guzman H; Sevrioukov E; Idica A; Park E; Bochnakian A; Daugaard I; Jury D; Mortazavi A; Zisoulis DG; Pedersen IM
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31010097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virus versus host plant microRNAs: who determines the outcome of the interaction?
    Maghuly F; Ramkat RC; Laimer M
    PLoS One; 2014; 9(6):e98263. PubMed ID: 24896088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo origination of MIRNAs through generation of short inverted repeats in target genes.
    Lu S
    RNA Biol; 2019 Jun; 16(6):846-859. PubMed ID: 30870071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid hormone may regulate mRNA abundance in liver by acting on microRNAs.
    Dong H; Paquette M; Williams A; Zoeller RT; Wade M; Yauk C
    PLoS One; 2010 Aug; 5(8):e12136. PubMed ID: 20808432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miRNA and cancer; computational and experimental approaches.
    Tutar Y
    Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the mRNA targetome of microRNAs expressed by Marek's disease virus.
    Parnas O; Corcoran DL; Cullen BR
    mBio; 2014 Jan; 5(1):e01060-13. PubMed ID: 24449754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol and prostate cancer: promising role for microRNAs.
    Dhar S; Hicks C; Levenson AS
    Mol Nutr Food Res; 2011 Aug; 55(8):1219-29. PubMed ID: 21714127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated miRNA and mRNA expression profiling reveals dysregulated miRNA-mRNA regulatory networks in eosinophilic and non-eosinophilic chronic rhinosinusitis with nasal polyps.
    Bu X; Wang M; Luan G; Wang Y; Wang C; Zhang L
    Int Forum Allergy Rhinol; 2021 Aug; 11(8):1207-1219. PubMed ID: 33611865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNA signature identification of retinoblastoma and the correlations between differentially expressed miRNAs during retinoblastoma progression.
    Yang Y; Mei Q
    Mol Vis; 2015; 21():1307-17. PubMed ID: 26730174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive Role of Cluster Bean (
    Sahu S; Rao AR; Sahu TK; Pandey J; Varshney S; Kumar A; Gaikwad K
    Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
    Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
    J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput sequencing of small RNA transcriptomes reveals critical biological features targeted by microRNAs in cell models used for squamous cell cancer research.
    Severino P; Oliveira LS; Torres N; Andreghetto FM; Klingbeil Mde F; Moyses R; Wünsch-Filho V; Nunes FD; Mathor MB; Paschoal AR; Durham AM
    BMC Genomics; 2013 Oct; 14():735. PubMed ID: 24160351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput mRNA and miRNA profiling of epithelial-mesenchymal transition in MDCK cells.
    Shukla P; Vogl C; Wallner B; Rigler D; Müller M; Macho-Maschler S
    BMC Genomics; 2015 Nov; 16():944. PubMed ID: 26572553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics Analyses of Potential miRNA-mRNA Regulatory Axis in HBV-related Hepatocellular Carcinoma.
    Huang DP; Zeng YH; Yuan WQ; Huang XF; Chen SQ; Wang MY; Qiu YJ; Tong GD
    Int J Med Sci; 2021; 18(2):335-346. PubMed ID: 33390802
    [No Abstract]   [Full Text] [Related]  

  • 16. Uncovering the potential differentially expressed miRNAs as diagnostic biomarkers for hepatocellular carcinoma based on machine learning in The Cancer Genome Atlas database.
    Zhao X; Dou J; Cao J; Wang Y; Gao Q; Zeng Q; Liu W; Liu B; Cui Z; Teng L; Zhang J; Zhao C
    Oncol Rep; 2020 Jun; 43(6):1771-1784. PubMed ID: 32236623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatics approach to predict target genes for dysregulated microRNAs in hepatocellular carcinoma: study on a chemically-induced HCC mouse model.
    Del Vecchio F; Gallo F; Di Marco A; Mastroiaco V; Caianiello P; Zazzeroni F; Alesse E; Tessitore A
    BMC Bioinformatics; 2015 Dec; 16():408. PubMed ID: 26652480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Metabolic Syndrome-Related miRNA-mRNA Regulatory Networks and Key Genes Based on Bioinformatics Analysis.
    Qiu L; Sheng P; Wang X
    Biochem Genet; 2023 Feb; 61(1):428-447. PubMed ID: 35877019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early microRNA indicators of PPARα pathway activation in the liver.
    Chorley BN; Carswell GK; Nelson G; Bhat VS; Wood CE
    Toxicol Rep; 2020; 7():805-815. PubMed ID: 32642447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma.
    Luo Z; Zhang L; Li Z; Li X; Li G; Yu H; Jiang C; Dai Y; Guo X; Xiang J; Li G
    BMC Med Genomics; 2012 Jan; 5():3. PubMed ID: 22260379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.